myopathy
This study was designed to investigate the effects of bezafibrate as a PPARalpha agonist on human embryo rhabdomyosarcoma (RD) cells and possible mechanisms responsible for bezafibrate-mediated myopathy.
This study was designed to investigate the effects of bezafibrate as a <span class="gene" id="19683050-3-71-80">PPARalpha</span> agonist on human embryo rhabdomyosarcoma (RD) cells and possible mechanisms responsible for bezafibrate-mediated <span class="disease" id="19683050-3-194-202">myopathy</span>.